|
Volumn 7, Issue 3, 2001, Pages 562-569
|
The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
CISPLATIN;
FLUOROURACIL;
GLUTATHIONE TRANSFERASE;
GLYCOPROTEIN P;
METALLOTHIONEIN;
THYMIDYLATE SYNTHASE;
ADULT;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER MORTALITY;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
DRUG MECHANISM;
ESOPHAGUS CANCER;
ESOPHAGUS RESECTION;
FEMALE;
GENE OVEREXPRESSION;
HUMAN;
HUMAN TISSUE;
IMMUNOHISTOCHEMISTRY;
MAJOR CLINICAL STUDY;
MALE;
MOLECULAR BIOLOGY;
MULTIDRUG RESISTANCE;
MULTIMODALITY CANCER THERAPY;
PRIORITY JOURNAL;
PROGNOSIS;
ADENOCARCINOMA;
ADULT;
AGE FACTORS;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BIOPSY;
CARCINOMA, SQUAMOUS CELL;
CISPLATIN;
DISEASE-FREE SURVIVAL;
ESOPHAGEAL NEOPLASMS;
FLUOROURACIL;
GLUTATHIONE S-TRANSFERASE PI;
GLUTATHIONE TRANSFERASE;
HUMANS;
IMMUNOHISTOCHEMISTRY;
ISOENZYMES;
METALLOTHIONEIN;
MIDDLE AGED;
MULTIVARIATE ANALYSIS;
P-GLYCOPROTEIN;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
THYMIDYLATE SYNTHASE;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 0034895131
PISSN: 10780432
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (79)
|
References (25)
|